NCT07630961
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +31 more
- Locations
-
- Novartis Investigative Site Chuo Ku, Tokyo, Japan
Clinical trial condition
HR+/HER2- Lobular Breast Cancer (BC)
Explore clinical trials studying HR+/HER2- Lobular Breast Cancer (BC). Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study